You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exfoliated peritoneal cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial in Oslo (Observational study.)

Active, not recruiting
  • Rectal Cancer
  • Observational study.
  • Oslo, Ullern, Norway
    The Norwegain Radium Hospital
Jul 21, 2021

Histopathology, Periodontitis, Smoking Trial in Istanbul

Completed
  • Histopathology
  • +3 more
    • Istanbul, Turkey
      Begüm Alkan
    Aug 15, 2022

    Detect Myometrial Cells in Peritoneal Washing in Patients

    Not yet recruiting
    • Hysterectomy
    • Peritoneal washings
    • Galveston, Texas
      University of Texas Medical branch
    Jul 13, 2023

    Malignant Pleural Effusion, Malignant Peritoneal Effusion Trial in Wuhan (Virus Activated Killer immune Cells, Saline)

    Recruiting
    • Malignant Pleural Effusion
    • Malignant Peritoneal Effusion
    • Virus Activated Killer immune Cells
    • Saline
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Sep 29, 2022

    Carcinoma Trial in Taoyuan City

    Recruiting
    • Carcinoma
      • Taoyuan City, Taiwan
        Chang Gung Memorial Hospital
      Feb 21, 2023

      Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (MOv19-BBz CAR T cells, Alpha Folate

      Recruiting
      • Ovarian Cancer
      • +2 more
      • MOv19-BBz CAR T cells
      • Alpha Folate Receptor expression test
      • Philadelphia, Pennsylvania
        University of Pennsylvania Health System
      Sep 12, 2022

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Active, not recruiting
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +11 more
      • Aldesleukin
      • +3 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jul 13, 2022

      Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in New Brunswick, Providence (anti-CEA CAR-T cells)

      Withdrawn
      • Peritoneal Carcinomatosis
      • +6 more
      • anti-CEA CAR-T cells
      • New Brunswick, New Jersey
      • +1 more
      Mar 25, 2022

      Lung Adenocarcinoma, Ovarian Cancer, Peritoneal Carcinoma Trial in Philadelphia (huCART-meso cells)

      Recruiting
      • Lung Adenocarcinoma
      • +5 more
      • huCART-meso cells
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Dec 1, 2022

      Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in

      Not yet recruiting
      • Stage II Fallopian Tube Cancer AJCC v8
      • +33 more
      • Alpha-type-1 Polarized Dendritic Cells
      • Autologous Natural Killer Cell-like CTLs
      • Buffalo, New York
        Roswell Park Cancer Institute
      Apr 1, 2022

      Long-term Peritoneal Dialysis Patients Who Eventually Develop

      Active, not recruiting
      • Ultrafiltration Failure
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Feb 11, 2023

        Malignant Peritoneal Effusion, Malignant Ascites, Serous Cavity Metastatises Trial in Chengdu (Dual-targeting VEGFR1 and PD-L1

        Not yet recruiting
        • Malignant Peritoneal Effusion
        • +2 more
        • Dual-targeting VEGFR1 and PD-L1 CAR-T cells
        • Chengdu, Sichuan, China
          West China Hospital, Sichuan University
        Jul 26, 2022

        A Prospective, Multi-centre, Single-blinded Study of UroCAD for

        Recruiting
        • Urothelial Carcinoma
        • The level of CNV
        • Shanghai, Shanghai, China
          Changhai Hospital
        Sep 8, 2021

        Peritoneal Damage Trial in Madrid (Low pressure pneumoperitoneum, standard pneumoperitoneum pressure)

        Completed
        Has Results
        • Peritoneal Damage
        • Low pressure pneumoperitoneum
        • standard pneumoperitoneum pressure
        • Madrid, Spain
          Ramon y Cajal Hospital
        Sep 21, 2021

        Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Buffalo

        Active, not recruiting
        • Recurrent Fallopian Tube Carcinoma
        • +2 more
        • Aldesleukin
        • +4 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        Mar 3, 2022

        Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal

        Completed
        • Ovarian Epithelial Cancer
        • +2 more
        • Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle
        • Graz, Austria
        • +13 more
        Sep 1, 2022

        Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

        Recruiting
        • Carcinoma, Ovarian Epithelial
        • +8 more
        • AB-1015
        • Iowa City, Iowa
          U. of Iowa Health Care
        Jan 30, 2023

        Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (biological, drug, other)

        Completed
        • Fallopian Tube Cancer
        • +2 more
        • filgrastim
        • +3 more
        • New York, New York
          Memorial Sloan-Kettering Cancer Center
        Aug 5, 2021

        Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in United States (AVOVA-1, MC)

        Active, not recruiting
        • Stage III Ovarian Carcinoma
        • +3 more
        • AVOVA-1
        • MC
        • Burbank, California
        • +5 more
        Apr 21, 2022

        EMT in Peritoneal Dialysis Patients

        Completed
        • Peritoneal Dialysis Complication
        • Isolation of peritoneal mesothelial cells
        • Aurora, Colorado
          University of Colorado Anschutz Medical Campus
        Feb 23, 2021

        Peritoneal Carcinoma Metastatic, Pleural Effusion, Malignant Trial in Chengdu (Dual-targeting HER2 and PD-L1 CAR-T cells)

        Active, not recruiting
        • Peritoneal Carcinoma Metastatic
        • Pleural Effusion, Malignant
        • Dual-targeting HER2 and PD-L1 CAR-T cells
        • Chengdu, Sichuan, China
          West China Hospital, Sichuan University
        Sep 21, 2021

        A Prospective, Single-centre,Single-blinded Study of PROUD for

        Recruiting
        • Prostate Carcinoma
        • The level of CNV
        • Jinan, Shandong, China
          Urology Department of Qiluhospital
        Jan 6, 2021

        Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Minneapolis (FATE-NK100, Interleukin-2)

        Completed
        • Epithelial Ovarian Cancer
        • +2 more
        • Minneapolis, Minnesota
          Masonic Cancer Center, University of Minnesota
        Mar 10, 2021

        Oral Premalignant and Malignant Lesions

        Recruiting
        • Oral Cancer
        • Diagnoses Disease
        • exfoliated cytology
        • Cairo, Egypt
          Faculty of Dentistry
        May 18, 2022

        Type2 Diabetes Trial in Shanghai (Stem Cells From Human Exfoliated Teeth)

        Completed
        • Type2 Diabetes
        • Stem Cells From Human Exfoliated Teeth
        • Shanghai, Shanghai, China
          Changhai hospital
        Feb 27, 2020